Literature DB >> 1176595

Purification of Japanese encephalitis virus vaccine by zonal centrifugation.

K Okuda, K Ito, K Miyake, M Morita, M Ogonuki.   

Abstract

A large-scale procedure for purification and concentration of Japanese encephalitis virus vaccine by a continuous-flow isopycnic banding technique in a sucrose density gradient solution, using a K-III zonal centrifuge rotor, is presented. The quality of zonal-purified vaccine was compared with commercial and Japanese National Institutes of Health reference vaccines for antigenicity, immunodiffusion, and allergic encephalitogenicity tests to show its high purity.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1176595      PMCID： PMC274950          DOI： 10.1128/jcm.1.1.96-101.1975

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  10 in total

1.  Noninfectious hemagglutinin and complement-fixing antigen of Japanese B encephalitis.

Authors:  M KITOAKA; C NISHIMURA
Journal:  Virology       Date:  1963-02       Impact factor: 3.616

2.  Techniques for hemagglutination and hemagglutination-inhibition with arthropod-borne viruses.

Authors:  D H CLARKE; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1958-09       Impact factor: 2.345

3.  Studies on Japanese B encephalitis virus vaccines from tissue culture. V. Response of man to live, antenuated strain of OCT-541 virus vaccine.

Authors:  W M Hammon; M A Darwish; J S Rhim; G E Sather; D S Yohn; A Mittelman; E Deverson; J P Soyka
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

4.  Studies on Japanese B encephalitis virus vaccines from tissue culture. VI. Development of a hamster kidney tissue culture inactivated vaccine for man. 3. Potency testing of an attenuated strain of OCT-541.

Authors:  M A Darwish; W M Hammon
Journal:  J Immunol       Date:  1966-05       Impact factor: 5.422

5.  Semi-commercial-scale production of Japanese B encephalitis virus vaccines from tissue culture.

Authors:  B Singh; I C Chang; W M Hammon
Journal:  Appl Microbiol       Date:  1973-06

6.  Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin.

Authors:  E H Eylar; J Salk; G C Beveridge; L V Brown
Journal:  Arch Biochem Biophys       Date:  1969-06       Impact factor: 4.013

7.  K-series centrifuges. I. Development of the K-II continuous-sample-flow-with-banding centrifuge system for vaccine purification.

Authors:  N G Anderson; D A Waters; C E Nunley; R F Gibson; R M Schilling; E C Denny; G B Cline; E F Babelay; T E Perardi
Journal:  Anal Biochem       Date:  1969-12       Impact factor: 3.365

8.  Allergic encephalomyelitis: a comparison of the encephalitogenic A1 protein from human and bovine brain.

Authors:  Y Oshiro; E H Eylar
Journal:  Arch Biochem Biophys       Date:  1970-06       Impact factor: 4.013

9.  Purification of influenza virus in the K-II zonal centrifuge.

Authors:  J L Gerin; N G Anderson
Journal:  Nature       Date:  1969-03-29       Impact factor: 49.962

10.  The proteins of Japanese encephalitis virus.

Authors:  D Shapiro; W E Brandt; R D Cardiff; P K Russell
Journal:  Virology       Date:  1971-04       Impact factor: 3.616
  10 in total
  2 in total

1.  Large-scale purification of Japanese encephalitis virus from infected mouse brain for preparation of vaccine.

Authors:  C Aizawa; S Hasegawa; C Chih-Yuan; I Yoshioka
Journal:  Appl Environ Microbiol       Date:  1980-01       Impact factor: 4.792

Review 2.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.